Lipodystrophy and metabolic complications of highly active antiretroviral therapy

Indian Journal of Pediatrics

Volumn 76, Issue 10, 2009, Pages 1017-1021

  Parakh, Ankit ^a   Dubey, Anand Prakash ^a   Kumar, Ajay ^a   Maheshwari, Anshu ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

Children; Dyslipidemia; HAART; India; Lipodystrophy

Indexed keywords

AMYLASE; ANTIRETROVIRUS AGENT; BICARBONATE; GLUCOSE; LACTIC ACID; LAMIVUDINE; LIPID; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

AGE DISTRIBUTION; AMYLASE BLOOD LEVEL; ARTICLE; BICARBONATE BLOOD LEVEL; BLOOD PH; BODY FAT DISTRIBUTION; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIET RESTRICTION; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; LACTATE BLOOD LEVEL; LIPID ANALYSIS; LIPOATROPHY; LIPODYSTROPHY; LIPOHYPERTROPHY; LIVER DYSFUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OBSERVATIONAL STUDY; PRESCHOOL CHILD; PREVALENCE; RISK FACTOR; SCHOOL CHILD; SOCIAL ASPECT; TREATMENT FAILURE; WORLD HEALTH ORGANIZATION;

AGE DISTRIBUTION; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; INDIA; INFANT; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; PROBABILITY; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TIME FACTORS;

EID: 70849135954     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12098-009-0216-9     Document Type: Article

References (26)

1. A. Carr K. Samaras A. Thorsidottir G.R. Kaufman D.J. Chisholm D.A. Cooper 1999 Diagnosis, prediction and natural course of HIV-1 protease inhibitor-associated lipodystrophy, hyperlipidaemia and diabetes mellitus: a cohort study Lancet 353 2093 2099 10.1016/S0140-6736(98)08468-2 1:STN:280:DyaK1MzhtVSltw%3D%3D 10382692 (Pubitemid 29278477)
2. C. Vigouroux S. Gharakhanian Y. Salhi T.H. Nguyen N. Adda W. Rozenbaum, et al. 1999 Adverse metabolic disorders during highly active antiretroviral treatments (HAART) of HIV disease Diabet Metab 25 383 392 1:CAS:528: DC%2BD3cXhsVOhtw%3D%3D
3. S. Safrin C. Grunfeld 1999 Fat distribution and metabolic changes in patients with HIV infection AIDS 13 2493 2505 10.1097/00002030-199912240-00002 1:STN:280:DC%2BD3c%2FpsVaitg%3D%3D 10630518 (Pubitemid 30038027)
4. M. John D. Nolan S. Mallal 2001 Antiretroviral therapy and the lipodystrophy syndrome Antivir Ther 6 9 20 1:CAS:528:DC%2BD38Xls1CnsLw%3D 11417766
5. D.S. Chen A. Misra A. Garg 2002 Clinical review 153: lipodystrophy in human immunodeficiency virus-infected patients J Clin Endocrinol Metab 87 4845 4856 10.1210/jc.2002-020794 1:CAS:528:DC%2BD38Xos1ynsrY%3D 12414837 (Pubitemid 35331060)
6. M.K. Leow C.L. Addy C.S. Mantzoros 2003 Clinical review 159. Human immunodeficiency virus/highly active antiretroviral therapy associated metabolic syndrome: clinical presentation, pathophysiology, and therapeutic strategies J Clin Endocrinol Metab 88 1961 1976 10.1210/jc.2002-021704 1:CAS:528: DC%2BD3sXjs1Oktrg%3D 12727939 (Pubitemid 36549862)
7. S.N. Pujari A. Dravid E. Naik S. Bhagat K. Tash J.P. Nadler, et al. 2005 Lipodystrophy and dyslipidemia among patients taking first-line, World Health Organizationrecommended highly active antiretroviral therapy regimens in Western India J Acquir Immune Defic Syndr 39 199 202 15905737
8. S. Saghayam S.K. Chaguturu N. Kumarasamy S. Solomon K.H. Mayer C. Wanke 2004 Lipoatrophy is the predominant presentation of HIV-associated lipodystrophy in southern India Clin Infect Dis 38 1646 1647 10.1086/392516 15156463 (Pubitemid 38738571)
9. R.A. Amaya C.A. Kozinetz A. McMeans H. Schwarzwald M.W. Kline 2002 Lipodystrophy syndrome in human immunodeficiency virus-infected children Pediatr Infect Dis J 21 405 410 10.1097/00006454-200205000-00011 12150177 (Pubitemid 34532934)
10. J.L. Bockhorst I. Ksseiry M. Toye S.R. Chipkin B.W. Stechenberg D.J. Fisher H.F. Allen 2003 Evidence of human immunodeficiency virus-associated lipodystrophy syndrome in children treated with protease inhibitors Pediatr Infect Dis J 22 463 465 10.1097/00006454-200305000-00017 12797313 (Pubitemid 36578754)
11. European Paediatric Lipodystrophy Group. 2004 Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIVinfected children in Europe AIDS 18 1443 1451 10.1097/01.aids.0000131334.38172.01 (Pubitemid 38925137)
12. A.M. Sánchez Torres R. Munoz Muniz R. Madero C. Borque M.J. García-Miguel M.I. De José Gómez 2005 Prevalence of fat redistribution and metabolic disorders in human immunodeficiency virus-infected children Eur J Pediatr 164 271 276 10.1007/s00431-004-1610-y 15650834 (Pubitemid 40613041)
13. P. Taylor C. Worrell S.M. Steinberg R. Hazra S. Jankelevich L.V. Wood, et al. 2004 Natural history of lipid abnormalities and fat redistribution among human immunodeficiency virus-infected children receiving long-term, protease inhibitorcontaining, highly active antiretroviral therapy regimens Pediatrics 114 e235 e242 10.1542/peds.114.2.e235 15286262
14. L. Ene T. Goetghebuer M. Hainaut A. Peltier V. Toppet J. Levy 2007 Prevalence of lipodystrophy in HIV-infected children: a cross-sectional study Eur J Pediatr 166 13 21 10.1007/s00431-006-0193-1 16896646 (Pubitemid 44900517)
15. K. Hartman G. Verweel R. de Groot N.G. Hartwig 2006 Detection of lipoatrophy in human immunodeficiency virus-1-infected children treated with highly active antiretroviral therapy Pediatr Infect Dis J 25 427 431 10.1097/01.inf.0000215003.32256.aa 16645507 (Pubitemid 43755097)
16. B. Ergun-Longmire K. Lin-Su A.M. Dunn L. Chan K. Ham C. Sison, et al. 2006 Effects of protease inhibitors on glucose tolerance, lipid metabolism, and body composition in children and adolescents infected with human immunodeficiency virus Endocr Pract 12 514 521 17014060
17. R.J. Carter J. Wiener E.J. Abrams J. Farley S. Nesheim P. Palumbo, et al. 2006 Perinatal AIDS Collaborative Transmission Study-HIV Follow-up after Perinatal Exposure (PACTS-HOPE) Group. Dyslipidemia among perinatally HIV-infected children enrolled in the PACTS-HOPE cohort, 1999-2004: a longitudinal analysis J Acquir Immune Defic Syndr 41 453 460 10.1097/01.qai.0000218344.88304.db 16652053 (Pubitemid 43756161)
18. F. Solórzano Santos L.G. Gochicoa Rangel G. Palacios Saucedo G. Vázquez Rosales M.G. Miranda Novales 2006 Hypertriglyceridemia and hypercholesterolemia in human immunodeficiency virus-1-infected children treated with protease inhibitors Arch Med Res 37 129 132 10.1016/j.arcmed.2005.05.013 16314198 (Pubitemid 41727902)
19. K. Lapphra N. Vanprapar W. Phongsamart P. Chearskul K. Chokephaibulkit 2005 Dyslipidemia and lipodystrophy in HIV-infected Thai children on highly active antiretroviral therapy (HAART) J Med Assoc Thai 88 956 966 16241026
20. M. Beregszaszi C. Dollfus M. Levine A. Faye S. Deghmoun N. Bellal, et al. 2005 Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIVinfected children J Acquir Immune Defic Syndr 40 161 168 10.1097/01.qai.0000178930.93033.f2 1:CAS:528:DC%2BD2MXhtVCltrbF 16186733 (Pubitemid 41395714)
21. World Health Organization. Scaling up Antiretroviral Therapy in Resourcelimited Settings: Treatment Guidelines for a Public Health Approach. Geneva: World Health Organization; 2003.
22. W.A. Marshall J.M. Tanner 1970 Variations in pattern of pubertal changes in boys Arch Dis Child 45 13 23 10.1136/adc.45.239.13 1:STN:280: DyaE3c7msVGrsQ%3D%3D 5440182
23. A. Carr S. Emery M. Law R. Puls J.D. Lundgren W.G. Powderly 2003 An objective case definition of lipodystrophy in HIVinfected adults: a case-control study Lancet 361 726 735 10.1016/S0140-6736(03)12656-6 1:STN:280: DC%2BD3s7gvVCiuw%3D%3D 12620736 (Pubitemid 36293626)
24. A. Carr M. Law 2003 An objective lipodystrophy severity grading scale derived from the lipodystrophy case definition score J Acquir Immune Defic Syndr 33 571 576 10.1097/00126334-200308150-00004 12902800 (Pubitemid 36975844)
25. R. Lauer L.A. Barness R. Clark 1992 Report of the expert panel on blood cholesterol levels in children and adolescents Pediatrics 89 525 584
26. Divisions of AIDS, National Institute of Allergy and Infectious Diseases. Toxicity table for grading severity of pediatric adverse experiences. April 1994. Available at: http://www.hptn.org/Web%20Documents/Regulatory-Resources.